High quality Covid-19 Testing Kit/The Diagnostic Kit for IgM / IgG Antibody to Coronavirus (SARS-CoV-2) (Lateral Flow)? ISO 9001:2015 REACH producer

Price	USD50.00
Packge	1BOX

Min. Order:1BOX
Supply Ability:50000
Time:2020-06-05

Product Details

Product NameCovid-19 Testing Kit

Sample type：

serum, plasma, venous whole blood

Pack Size：

10 Test Sets /Kit; 20 Test Sets /Kit;50 Test Sets /Kit

Storage Condition：

2°C～30°C

Interpretation of Test Result：

10 minutes to interpret the result

Detection mode：

single detection, separate detection of IgM and IgG, the two results are non-interference and can complement each other

Key Advantage

•Rapid-screening within 10 minutes.No testing equipments required.

•High detection efficiency: simultaneous monitoring of IgM and IgG.

•Detection without any testing equipments .

•Easy to operate, and is compatible with serum/ plasma.

•Room-temperature storage.

Product Description

Both IgM and IgG are immunoglobulin which are produced by the immune system to provide protectionagainst the 2019-nCoV. Some patients with negative results in nucleic acid test show positive in IgM test,indicating that the IgG / IgM detection is one of the effective methods for the diagnosis of 2019-nCoV.

The level of IgM antibody begins to rise after 1 week after the initial infection, while the IgG appears later than IgM (usually in 14 days after infection) and can last for 6 months or even several years, which meansthat the IgG serves as an indicator of previous infection. Suspected patients that are infected by 2019-nCoV can be rapidly identified by simultaneous monitoring of IgM and IgG. During the outbreak period of2003-SARS and the 2016-Zika, IgM / IgG antibody detection was used as one of the recommendeddiagnostic methods.

Company Profile Introduction

Dideu Medichem always takes on some of the human biggest healthcare challenges. It delivers a sustainable business and health benefits to patients through its high quality products. Dideu develops a broad range of products in pharmaceuticals, vaccines and consumer healthcare, and has leading products across various therapeutic areas including cardiovascular and respiratory disease,neurological disorders, asthma, cancer, infections, mental health, gastrointestinal infection,diabetes and digestive conditions. It is one of the best companies to have a good growth in emerging markets recent years; Dideu is improving people’s quality of life by preventing, alleviating and treating diseases. And we are also have subsidiary company helping to provide a reliable supply of high quality green agrucutural chemical, high-quality food, feed and plant-based raw materials.We develop new molecules for use in innovative products and solutions to improve health. Our research and development activities are based on a profound understanding of the biochemical processes in living organisms.Our goal is to achieve and sustain leadership positions in our markets, thus creating value for our customers, stockholders and employees. To this end, our strategy is designed to help solve some of the most pressing challenges facing humankind, and by doing this exceptionally well we aim to strengthen the company’s earning power. We are committed to operating sustainably and addressing our social and ethical responsibilities as a corporate citizen, while at the same time respecting the interests of all our stakeholders. Employees with a passion for innovation enjoy excellent development opportunities at Dideu. Pharmaceuticals Subsidiary The Pharmaceuticals Division, our largest in terms of sales, is focused on the following areas in which we aim to make decisive contributions to medical progress: oncology, cardiology and hematology, gynecology, neurology, infectious diseases, men’s health, ophth

Recommended supplier

Carol Petroleum Private Limited
Covid Disinfectant Chemical, For Industrial
Inquiry
2025-09-23

Shaanxi Dideu Medichem Co. Ltd

Shaanxi China

Since:2016-08-09
Address: No. 381, Dingkunchi Road, High-tech Park, Xi'an, Shaanxi Province

INQUIRY